» Articles » PMID: 33751761

Kidney Tubule Health Scores and Their Associations with Incident CKD in Women Living with HIV

Overview
Journal HIV Med
Publisher Wiley
Date 2021 Mar 22
PMID 33751761
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Individual kidney tubule biomarkers are associated with chronic kidney disease (CKD) risk in people living with HIV (PLWH). Whether a combination of kidney biomarkers can be integrated into informative summary scores for PLWH is unknown.

Methods: We measured eight urine biomarkers of kidney tubule health at two visits over a 3-year period in 647 women living with HIV in the Women's Interagency Health Study. We integrated biomarkers into factor scores using exploratory factor analysis. We evaluated associations between CKD risk factors and factor scores, and used generalized estimating equations to determine associations between factor scores and risk of incident CKD.

Results: Factor analysis identified two unique factor scores: a tubule reabsorption score comprising alpha-1-microglobulin, beta-2-microglobulin and trefoil factor-3; and a tubule injury score comprising interleukin-18 and kidney injury molecule-1. We modelled the two factor scores in combination with urine epidermal growth factor (EGF) and urine albumin. Predominantly HIV-related CKD risk factors were independently associated with worsening tubule reabsorption scores and tubule injury scores. During a median follow-up of 7 years, 9.7% (63/647) developed CKD. In multivariable time-updated models that adjusted for other factor scores and biomarkers simultaneously, higher tubule reabsorption scores [risk ratio (RR) = 1.27, 95% confidence interval (CI): 1.01-1.59 per 1 SD higher time-updated score], higher tubule injury scores (RR = 1.36, 95% CI: 1.05-1.76), lower urine EGF (RR = 0.75, 95% CI: 0.64-0.87), and higher urine albumin (RR = 1.20, 95% CI: 1.02-1.40) were jointly associated with risk of incident CKD.

Conclusions: We identified two novel and distinct dimensions of kidney tubule health that appear to quantify informative metrics of CKD risk in PLWH.

Citing Articles

Phenotyping Kidney Function in Young Adults With High Blood Pressure: The African-PREDICT Study.

Degenaar A, Kruger R, Jacobs A, Mels C J Clin Hypertens (Greenwich). 2024; 26(11):1291-1300.

PMID: 39368068 PMC: 11555542. DOI: 10.1111/jch.14911.


Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies.

Amatruda J, Katz R, Rebholz C, Sarnak M, Gutierrez O, Schrauben S Kidney Med. 2024; 6(6):100834.

PMID: 38826568 PMC: 11141432. DOI: 10.1016/j.xkme.2024.100834.


HIV at 40: kidney disease in HIV treatment, prevention, and cure.

Lucas A, Wyatt C Kidney Int. 2022; 102(4):740-749.

PMID: 35850290 PMC: 9509437. DOI: 10.1016/j.kint.2022.06.021.


Urine Alpha-1-Microglobulin Levels and Acute Kidney Injury, Mortality, and Cardiovascular Events following Cardiac Surgery.

Amatruda J, Estrella M, Garg A, Thiessen-Philbrook H, McArthur E, Coca S Am J Nephrol. 2021; 52(8):673-683.

PMID: 34515046 PMC: 8619798. DOI: 10.1159/000518240.

References
1.
Jotwani V, Li Y, Grunfeld C, Choi A, Shlipak M . Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2011; 59(5):628-35. PMC: 3324595. DOI: 10.1053/j.ajkd.2011.10.050. View

2.
Taupin D, Podolsky D . Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003; 4(9):721-32. DOI: 10.1038/nrm1203. View

3.
Muiru A, Scherzer R, Ascher S, Jotwani V, Grunfeld C, Shigenaga J . Associations of CKD risk factors and longitudinal changes in urine biomarkers of kidney tubules among women living with HIV. BMC Nephrol. 2021; 22(1):296. PMC: 8406753. DOI: 10.1186/s12882-021-02508-6. View

4.
Birn H, Christensen E . Renal albumin absorption in physiology and pathology. Kidney Int. 2006; 69(3):440-9. DOI: 10.1038/sj.ki.5000141. View

5.
Bacon M, von Wyl V, Alden C, Sharp G, Robison E, Hessol N . The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005; 12(9):1013-9. PMC: 1235804. DOI: 10.1128/CDLI.12.9.1013-1019.2005. View